The antibody therapeutics market, biologics drug development, and monoclonal antibody technology are transforming the treatment landscape for cancer, autoimmune disorders, infectious diseases, and chronic inflammatory conditions. Over the past two decades, biologic medicines have shifted the focus of healthcare from symptom management to targeted therapies that interact with...